Skip to content
Tiatra, LLCTiatra, LLC
Tiatra, LLC
Information Technology Solutions for Washington, DC Government Agencies
  • Home
  • About Us
  • Services
    • IT Engineering and Support
    • Software Development
    • Information Assurance and Testing
    • Project and Program Management
  • Clients & Partners
  • Careers
  • News
  • Contact
 
  • Home
  • About Us
  • Services
    • IT Engineering and Support
    • Software Development
    • Information Assurance and Testing
    • Project and Program Management
  • Clients & Partners
  • Careers
  • News
  • Contact

The bigger the better? Approaching Generative AI by size

As the Generative AI (GenAI) hype continues, we’re seeing an uptick of real-world, enterprise-grade solutions in industries from healthcare and finance, to retail and media. As the technology matures, we’re also learning more about its potential, shortcomings, and barriers to entry—ethical considerations, accuracy, hallucinations, and more. But beyond industry, however, there are factors that play into the success or failure of Generative AI projects. 

One of those lesser talked about factors is company size. A recently conducted survey by Gradient Flow explores the state of GenAI in healthcare, an industry that’s been on the pulse of the technology since inception. Among other findings, the results show clear discrepancies in the way companies of differing sizes approach adoption, implementation, and priorities of AI. 

From budget allocations to model preferences and testing methodologies, the survey unearths the areas that matter most to large, medium, and small companies, respectively. Understanding these nuances can lead to more targeted solutions, higher adoption rates, and less false hope around the transformative power of GenAI. 

Large companies

Large organizations, defined as those with over 5,000 employees, had substantial resources and a strategic focus on evaluation and implementation of GenAI projects. These companies had the highest percentage of respondents actively evaluating GenAI use cases (26%), reflecting their capacity to invest in extensive research and development initiatives.

They also have the means to back it up. GenAI budget increases were significant, with 12% of respondents reporting an increase of more than 300% compared to the previous year. This financial commitment indicates a strong belief in the potential of GenAI to enhance various facets of healthcare delivery and administration. The emphasis on substantial budget hikes also suggests that large companies are not just experimenting with GenAI but are seriously investing in its integration and scaling.

With a clear preference (54%) for healthcare-specific, task-oriented language models, as opposed to general purpose large language models (LLMs), the desire for precise, reliable outputs in critical healthcare applications is clear. Despite more resources and use cases, the preference is to outsource expertise. The high adoption rate of proprietary LLMs through SaaS APIs (cloud-based) in these organizations indicates a preference to rely on third party vendors to drive the AI strategy and implementation. 

Not surprisingly, fairness and private data leakage were top priorities cited when it comes to testing and evaluation of GenAI models, likely due to the high-compliance environment of healthcare and potential reputational damage. The complexity and scale of operations in large organizations necessitate robust testing frameworks to mitigate these risks and remain compliant with industry regulations. 

Medium companies

Medium-sized companies—501 to 5,000 employees—were characterized by agility and a strong focus on GenAI experimentation. These organizations have the highest percentage (24%) of respondents engaged in experimenting and developing AI models, showcasing their ability to adapt quickly and innovate without the bureaucratic constraints that affect their larger counterparts.

Similar to large companies, GenAI budgets are healthy and on the rise just a size down, with 36% of respondents reporting a budget increase of 50-100%. This significant investment points to a growing recognition of GenAI’s potential to drive operational efficiency and innovation in healthcare.

Healthcare-specific task-oriented models were also highly favored, with more than half (57%) of respondents using these models. However, testing priorities differed slightly, with a stronger emphasis on explainability and hallucinations/disinformation. This suggests that medium-sized organizations are keenly aware of the importance of maintaining trust and accuracy in AI-driven healthcare solutions, especially as they scale their AI initiatives.

Small companies

Small companies, with less than 500 employees, represented nearly a third of the survey respondents and exhibited a pragmatic approach to GenAI adoption. Resource constraints and the need for immediate, tangible benefits are likely to have shaped their more cautious, results-focused approach. 

As such, small companies had the highest percentage (39%) of respondents not actively considering GenAI as a business solution. This hesitancy can be attributed to budget limitations and the high costs associated with deploying advanced AI solutions. However, of the small companies that are using GenAI, budget increases of 10-50% were reported, showing momentum. 

Patient-facing applications are a priority for small companies, with high adoption rates for use cases like answering patient questions (38%) and medical chatbots (36%). These applications offer immediate, visible benefits, enhancing patient engagement and communication without requiring extensive resources or infrastructure.

Small companies place a higher emphasis on supervised fine-tuning (39%) and de-biasing tools and techniques, showcasing a commitment to ensuring model accuracy and fairness. Testing priorities also include bias and freshness, indicating a focus on maintaining relevant and unbiased AI outputs that can adapt to changing healthcare needs.

Universal challenges and benefits 

While company size brings different GenAI challenges, some are universally acknowledged. Accuracy, security, and privacy risks are top concerns across the board, reflecting the high stakes associated with AI in healthcare. The potential for legal and reputational risks is being felt by all organizations, highlighting the need for robust mitigation strategies.

It’s not all bad news, though. The survey showed a shared belief in the transformative potential of GenAI, particularly in patient-facing applications like transcribing doctor-patient conversations and providing medical chatbots. While the pathways to adoption differ markedly, healthcare organizations of all sizes are meeting GenAI where they are. The 2024 Generative AI in Healthcare Survey brings to light the strategies and priorities influencing healthcare. While large companies drive extensive evaluation and investment, small- and medium-sized companies bring agility and pragmatism to the forefront. Each approach reflects the unique challenges and opportunities inherent to different scales of operation. Understanding this will not only help create better, more tailored AI solutions, but make the technology more accessible to all.


Read More from This Article: The bigger the better? Approaching Generative AI by size
Source: News

Category: NewsOctober 3, 2024
Tags: art

Post navigation

PreviousPrevious post:Things get nasty in lawsuit between WordPress.org and WP EngineNextNext post:Suncor Energy derives business value through business AI and automation

Related posts

휴먼컨설팅그룹, HR 솔루션 ‘휴넬’ 업그레이드 발표
May 9, 2025
Epicor expands AI offerings, launches new green initiative
May 9, 2025
MS도 합류··· 구글의 A2A 프로토콜, AI 에이전트 분야의 공용어 될까?
May 9, 2025
오픈AI, 아시아 4국에 데이터 레지던시 도입··· 한국 기업 데이터는 한국 서버에 저장
May 9, 2025
SAS supercharges Viya platform with AI agents, copilots, and synthetic data tools
May 8, 2025
IBM aims to set industry standard for enterprise AI with ITBench SaaS launch
May 8, 2025
Recent Posts
  • 휴먼컨설팅그룹, HR 솔루션 ‘휴넬’ 업그레이드 발표
  • Epicor expands AI offerings, launches new green initiative
  • MS도 합류··· 구글의 A2A 프로토콜, AI 에이전트 분야의 공용어 될까?
  • 오픈AI, 아시아 4국에 데이터 레지던시 도입··· 한국 기업 데이터는 한국 서버에 저장
  • SAS supercharges Viya platform with AI agents, copilots, and synthetic data tools
Recent Comments
    Archives
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • August 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • January 2024
    • December 2023
    • November 2023
    • October 2023
    • September 2023
    • August 2023
    • July 2023
    • June 2023
    • May 2023
    • April 2023
    • March 2023
    • February 2023
    • January 2023
    • December 2022
    • November 2022
    • October 2022
    • September 2022
    • August 2022
    • July 2022
    • June 2022
    • May 2022
    • April 2022
    • March 2022
    • February 2022
    • January 2022
    • December 2021
    • November 2021
    • October 2021
    • September 2021
    • August 2021
    • July 2021
    • June 2021
    • May 2021
    • April 2021
    • March 2021
    • February 2021
    • January 2021
    • December 2020
    • November 2020
    • October 2020
    • September 2020
    • August 2020
    • July 2020
    • June 2020
    • May 2020
    • April 2020
    • January 2020
    • December 2019
    • November 2019
    • October 2019
    • September 2019
    • August 2019
    • July 2019
    • June 2019
    • May 2019
    • April 2019
    • March 2019
    • February 2019
    • January 2019
    • December 2018
    • November 2018
    • October 2018
    • September 2018
    • August 2018
    • July 2018
    • June 2018
    • May 2018
    • April 2018
    • March 2018
    • February 2018
    • January 2018
    • December 2017
    • November 2017
    • October 2017
    • September 2017
    • August 2017
    • July 2017
    • June 2017
    • May 2017
    • April 2017
    • March 2017
    • February 2017
    • January 2017
    Categories
    • News
    Meta
    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    Tiatra LLC.

    Tiatra, LLC, based in the Washington, DC metropolitan area, proudly serves federal government agencies, organizations that work with the government and other commercial businesses and organizations. Tiatra specializes in a broad range of information technology (IT) development and management services incorporating solid engineering, attention to client needs, and meeting or exceeding any security parameters required. Our small yet innovative company is structured with a full complement of the necessary technical experts, working with hands-on management, to provide a high level of service and competitive pricing for your systems and engineering requirements.

    Find us on:

    FacebookTwitterLinkedin

    Submitclear

    Tiatra, LLC
    Copyright 2016. All rights reserved.